FII/FPI Trading Activity in Capital Market From CapitalHeight

The data is based on today's activity compiled on the basis of trading codes entered by trading members at the time of order entry and corresponding client category classification provided by trading members as part of unique client code details upload. This trade data is provisional and subject to change, inter alia, on account of custodial confirmation process, modifications etc. 

For More Detail About It click here: CapitalHeight.

                   FII ACTIVITY (Rs. in crores)

                 DII ACTIVITY (Rs. in crores)

                    TECHNICAL ANALYSIS STOCK
The stock share price of DR LAL PATHLABS is recently forms a flag chart pattern up move on daily and weekly. The company is good fundamentals & some Mutual Fund holding are strong believers of its capabilities. The stock has reversed trend and has become bullish. Huge volume is also confirming the same. The stock giving an opportunity of channel trade here as 723 was a past support becoming a resistance line now 930. On breaking 930 on closing basis DR LAL PATHLAB long around 930 for Target 975 - 1045 stop loss below 837.

Diagnostic chain DR LAL PATHLABS revenue, EBITDA and PAT grew 21%, and 30% YoY in Q4FY18 and beat estimates in margin and earnings. Revenue growth was aided by lower base (YoY) due to demonetization and product mix that drove higher contribution of bundle‐test package. Its margin improved due to rationalization on the number of clinical labs and re‐routing many tests to central lab in Delhi. Patient volumes increased by 21% QoQ.'